AU1970197A - Use of steroid compounds to prevent non-cancerous tissue growth - Google Patents

Use of steroid compounds to prevent non-cancerous tissue growth

Info

Publication number
AU1970197A
AU1970197A AU19701/97A AU1970197A AU1970197A AU 1970197 A AU1970197 A AU 1970197A AU 19701/97 A AU19701/97 A AU 19701/97A AU 1970197 A AU1970197 A AU 1970197A AU 1970197 A AU1970197 A AU 1970197A
Authority
AU
Australia
Prior art keywords
tissue growth
cancerous tissue
prevent non
steroid compounds
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19701/97A
Inventor
Abbot F. Clark
Stephen M. Goode
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU1970197A publication Critical patent/AU1970197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
AU19701/97A 1996-05-09 1997-02-21 Use of steroid compounds to prevent non-cancerous tissue growth Abandoned AU1970197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1906096P 1996-05-09 1996-05-09
US60019060 1996-05-09
PCT/US1997/002809 WO1997041867A1 (en) 1996-05-09 1997-02-21 Use of steroid compounds to prevent non-cancerous tissue growth

Publications (1)

Publication Number Publication Date
AU1970197A true AU1970197A (en) 1997-11-26

Family

ID=21791213

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19701/97A Abandoned AU1970197A (en) 1996-05-09 1997-02-21 Use of steroid compounds to prevent non-cancerous tissue growth

Country Status (2)

Country Link
AU (1) AU1970197A (en)
WO (1) WO1997041867A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000515523A (en) 1996-07-22 2000-11-21 ザ・ビクトリア・ユニバーシティ・オブ・マンチェスター Use of sex steroid function modulators in the treatment of wounds and fibrotic disorders
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
JP2000309599A (en) * 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd Estra-1,3,5(10),16-tetraene derivative
JP2007500250A (en) * 2003-06-13 2007-01-11 アルコン，インコーポレイテッド Nonsteroidal anti-inflammatory drug formulations for treating pathological ocular angiogenesis
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
EP1841780B1 (en) 2005-01-10 2011-07-27 Glaxo Group Limited Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
CA2631838A1 (en) * 2005-12-23 2007-07-05 Alcon, Inc. Use of anecortave acetate as an adjunct during filtration bleb surgery

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939135A (en) * 1988-10-03 1990-07-03 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
AU678961B2 (en) * 1991-11-22 1997-06-19 Alcon Laboratories, Inc. Angiostatic steroids

Also Published As

Publication number Publication date
WO1997041867A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
AU2557397A (en) Removal of tissue
AU2695795A (en) Piperazine compounds promote release of growth hormone
AU1721697A (en) Use of compositions comprising stabilized biologically effective compounds
PL321590A1 (en) Compounds capable to cause liberation of the growth hormone
AU5520998A (en) Reduction of hair growth
AU3599597A (en) Reduction of hair growth
AU5730298A (en) Reduction of hair growth
AU2340397A (en) Use of nicotine to treat liver disease
AU2681997A (en) Non-invasive enzyme screen for tissue remodelling-associated conditions
AU5005697A (en) Methods of preventing breast cancer
AU5427398A (en) Cytoperfusion of tissue specimens
AU3145795A (en) Fibrin-cell suspension for construction of new tissue
AU1970197A (en) Use of steroid compounds to prevent non-cancerous tissue growth
AU2969597A (en) Treatment of vascular lesions
AU1942995A (en) New use of growth hormone
AU2183597A (en) Biological electrostimulator of viscera
AU6412599A (en) Oxybutynin formulations and methods of use
AU1451200A (en) Dual reporter system and methods of use therefor
AU4256297A (en) Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2-substituted ethyl-2-amines
AU5890796A (en) Table-made of vegetable substance
AU4954597A (en) Self-adhesive patch for application to the skin
AU5126298A (en) Inhibition of crib-biting
AU9756898A (en) Human prostaglandin receptors and methods of use thereof
AU3849395A (en) Compaction of soil
AU2595297A (en) Use of aminoalkylcarboxylic derivatives